Cambridge Investment Research Advisors’s NuStar GP Holdings LLC NSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-10,181
Closed -$249K 2089
2017
Q2
$249K Sell
10,181
-2,756
-21% -$71.3K ﹤0.01% 1630
2017
Q1
$362K Buy
12,937
+2,122
+20% +$62.6K 0.01% 1256
2016
Q4
$313K Buy
10,815
+14
+0.1% +$359 0.01% 1248
2016
Q3
$276K Sell
10,801
-386
-3% -$9.44K 0.01% 1353
2016
Q2
$287K Buy
11,187
+14
+0.1% +$341 0.01% 1198
2016
Q1
$232K Sell
11,173
-1,951
-15% -$34.6K 0.01% 1321
2015
Q4
$278K Buy
13,124
+861
+7% +$20.8K 0.01% 1161
2015
Q3
$328K Buy
12,263
+510
+4% +$16.5K 0.01% 985
2015
Q2
$447K Buy
11,753
+8
+0.1% +$300 0.01% 867
2015
Q1
$416K Buy
11,745
+4,683
+66% +$166K 0.01% 886
2014
Q4
$243K Buy
7,062
+8
+0.1% +$296 0.01% 1109
2014
Q3
$307K Buy
7,054
+69
+1% +$2.9K 0.01% 1083
2014
Q2
$273K Sell
6,985
-4,216
-38% -$148K 0.01% 1049
2014
Q1
$381K Buy
+11,201
New +$341K 0.01% 840

Other funds holding NSH

Cambridge Investment Research Advisors's NSH Position: Q3 2017 in Review

Cambridge Investment Research Advisors sold out of NuStar GP Holdings LLC (NSH) in Q3 2017, closing a stake of 10,181 shares — an estimated $249K sold.

Cambridge Investment Research Advisors first reported a position in NSH in Q1 2014 and held it in 14 quarters. The position peaked at $447K in Q2 2015. 70 funds tracked by Wall St. Rank hold NSH as of Q3 2017.

  • Cambridge Investment Research Advisors reported no remaining NuStar GP Holdings LLC position as of Q3 2017 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,181 NuStar GP Holdings LLC shares in Q3 2017, an estimated $249K.
  • Cambridge Investment Research Advisors first reported a position in NuStar GP Holdings LLC in Q1 2014 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's NuStar GP Holdings LLC position peaked at $447K in Q2 2015.
  • 70 funds tracked by Wall St. Rank held NuStar GP Holdings LLC as of Q3 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.